Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Lead Mondays Market News West Bengal Set to Implement PM Vishwakarma Scheme for Artisan Support Following Central Approval Global Stocks Rise Yields Dip as USIran Talks Show Progress Dow Hits Record High AnheuserBusch InBev Shares Dip on Sales Miss Market Reacts to Revenue Shortfall Why Loyalty to One Airline Program Could Cost You The Case for Diversifying Credit Card Rewards Bloom Energy Secures 26B Deal Signaling Potential Growth PTC Q1 2026 Earnings Strong EPS Beat Fuels Cautious Optimism Amid Slight Stock Dip Stratasys SSYS Q1 2026 Earnings NarrowerThanExpected Loss Sparks Positive Reaction ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Phase NeoVolta Inc NEOV Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Climbs Netcapital Inc NCPL Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment VNDA Q1 2026 Earnings WiderThanExpected Loss Raises Concerns NL Industries Inc NL Surges 538 Key Levels and Technical Outlook Sabesp SBS Hovers Near Support as Modest Decline Continues Palisade Bio Inc PALI Edges Higher on Modest Volume Testing Resistance Levels Heartbeam Inc Warrant BEATW Slumps 23 A Tight Trading Range at 007 Calamos Global Total Return Fund CGO Gains 124 Approaches Key Resistance at 1460 Amazon Expands AI Shopping Technology to ThirdParty Retailers Starting with Kate Spade CPNG Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Empire Petroleum EP Surges Over 12 as Energy Sector Momentum Builds OneSpaWorld Holdings OSW Holds Steady Amidst Subtle Market Pressure Opendoor Technologies OPEN Jumps 6 as Home Resale Platform Shows Early Signs of Recovery Blackrock MuniHoldings New Jersey Quality Fund MUJ Edges Higher Amid Steady Demand Design Therapeutics DSGN Edges Higher as Support Holds Above 1060 NWPX Infrastructure Inc NWPX Posts Modest Gain Trading Between Key Support and Resistance Spark I Acquisition Corp SPKL Faces Selling Pressure Testing Key Support Levels Kiniksa Pharmaceuticals Holds Steady Near 54 as Stock Tests Key Resistance Levels